The “ah-ha!” moment for Organigram Holdings Inc. Chief Executive Greg Engel came on March 9, when he was able to see a visible shift in the anxiety that Canadian authorities — including the Minister of Health — showed about the spread of COVID-19.
Organigram eventually became one of the first cannabis companies to start discussing and disclosing the coronavirus’ expected impact on its operations. publicly making changes to its operations in response to COVID-19 in February. Engel said that the implications of the virus’s spread around the world became apparent as Organigram executives engaged in discussions with Canadian provincial officials, who acted quickly to implement social distancing and other measures, and federal authorities.
See also:Pot shops are considered ‘essential’ businesses in most states where it’s legal, but the rules are shifting “We had a facility inside a hospital where SARS was live,” he said. “I came at it with a different perspective, I certainly had a sense we had to take measures for safety reasons.” “It was material information and from a market perspective, we did need to give guidance,” Engel said.